Principal Investigator
Moffitt Cancer Center
Tampa, Florida, United States
Ana P. Gomes is an Assistant Member of the Department of Molecular Oncology at the Moffitt Cancer Center. She received a PhD in Cell and Molecular Biology from the University of Coimbra (Portugal) and did her PhD work under the supervision of Dr. David Sinclair at Harvard Medical School studying the role of NAD+ in skeletal muscle aging. Ana subsequently completed her postdoctoral training with Dr. John Blenis at Weill Cornell Medicine, studying the influence of age-driven metabolic and epigenetic reprogramming in tumor progression. Her laboratory aims to define how aging and other aspects of host physiology shape the tumorigenic process by taking a multidisciplinary approach, which encompasses cancer cell autonomous and non-autonomous mechanisms of tumor progression spanning from signaling paradigms to epigenetic reprogramming and metabolic rewiring. Ana has previously received a New Innovator Award (DP2) from the office of the NIH director, an Innovator Award from the American Lung Association, a Research Scholar Award from the American Cancer Society, a K99/R00 Pathway to Independence award from the National Institutes of Cancer, the Tri-Institutional Breakout Prize for Junior Investigators and was selected as a Forbeck Scholar, a NCI Rising Scholar, a STAT Wunderkind and a Rising Star in Cancer Metabolism and Signaling by the New York Academy of Sciences.
Disclosure information not submitted.
Presidential Symposium: Extending Healthspan and Longevity
Thursday, November 9, 2023
8:00 AM – 9:30 AM ET
2 - Age-Induced Systemic Reprogramming Drives Drug Resistance in Lung Cancer
Thursday, November 9, 2023
8:00 AM – 9:30 AM ET